Companies / Incyte Corp

Incyte Corp

Nasdaq: INCYCIK 879169Health CareWILMINGTON, DEincyte.com ↗

Financials · FY2025

Revenue$5.14B
Net income$1.29B
Total debt$19.01B
Cash$3.46B
Diluted EPS$6.41
Shares outstanding202.7M

Ownership

202.7M shares outstanding · as of Jul 21, 2026
14.2%Insiders
Ownership
Insiders14.17%28,717,089
Institutions83.97%170,205,105
Public float1.86%3,775,552

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 18

View all →
Insider% of sharesShares
Baker Bros. Advisors LPDirector · 10% owner
13.91%28,205,360
Cagnoni Pablo JPresident, Global Head of R&D
0.12%240,848
Issa Mohamed KhairieEVP, Head of US Oncology
0.03%66,132
Heeson LeeEVP, Head of Incyte Intl
0.02%38,041
Stein Steven HEVP & Chief Medical Officer
0.02%34,203
Morrissey Michael JamesEVP, Head of Tech. Operations
0.02%34,065
Bienaime Jean JacquesDirector
0.01%24,424
Clancy Paul JDirector
0.01%23,476
Harrigan EdmundDirector
0.01%22,764
Trotta MatteoEVP, GM, Dermatology US
<0.01%14,882

Institutional holders 828

View all →
HolderValue% of shares
Baker Bros. Advisors LP$2.89B15.17%
BlackRock, Inc.$2.04B8.90%
Vanguard Group Inc$1.97B9.82%
Dodge &amp; Cox$1.31B6.54%
State Street Corporation$1.10B4.80%
AQR Capital Management, LLC$536.13M2.87%
Geode Capital Management, LLC$441.08M2.32%
Renaissance Technologies LLC$343.68M1.80%
Invesco Ltd.$343.11M1.71%
Arrowstreet Capital, Limited Partnership$266.43M1.40%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 1, 2026Cagnoni Pablo J
Executive
OtherCommon Stock$2.43M-25K
-9.56%
240,848
0.12% of shares
low
Feb 19, 2026Cagnoni Pablo J
Executive
SellCommon Stock$1.88M-19K
-7.36%
234,800
0.12% of shares
medium
Apr 17, 2026Cagnoni Pablo J
Executive
SellCommon Stock$1.80M-19K
-6.63%
262,692
0.13% of shares
medium
Mar 17, 2026Cagnoni Pablo J
Executive
SellCommon Stock$1.76M-19K
-7.36%
234,800
0.12% of shares
medium
Jan 5, 2026Stein Steven H
Executive
SellCommon Stock$1.59M-16K
-31.37%
34,203
0.02% of shares
medium
Dec 31, 2025Stein Steven H
Executive
OtherCommon Stock$1.31M-13K
-21.06%
49,837
0.02% of shares
low
May 26, 2026Bienaime Jean Jacques
Director
OtherCommon Stock$1.27M-13K
-36.44%
22,782
0.01% of shares
low
May 26, 2026Bienaime Jean Jacques
Director
ExerciseCommon Stock$1.27M+15K
+71.97%
35,841
0.02% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
INCY——45337C102—